Fortis Healthcare Limited has disclosed the receipt of GST orders from Tamil Nadu authorities with significant financial implications totaling ₹2,139.61 crores. The healthcare major made this disclosure under Regulation 30 of SEBI Listing Obligations and Disclosure Requirements Regulations on December 30, 2025.

GST Orders and Financial Impact

The GST Authority from State Tax Officer (ST) - Group IX, Chengalpattu Intelligence Division, Tamil Nadu had initially issued show cause notices across three financial years. The confirmed demands following the company's response are substantially higher than the initial notices.

Timeline of Events

The GST orders were received on specific dates in December 2025:

• FY 2020-21 Order: December 29, 2025 at 5:46 PM
• FY 2021-22 Order: December 29, 2025 at 5:53 PM
• FY 2022-23 Order: December 30, 2025 at 4:38 PM

Regulatory Compliance

The company has fulfilled its disclosure obligations under SEBI regulations by providing detailed information about the litigation. The disclosure includes comprehensive details about the opposing party, the nature of disputes, and expected financial implications. Fortis Healthcare noted that show cause notices related to balance amounts beyond the confirmed demands have been dropped by the GST Authority.

Company Response

Following the initial show cause notices, Fortis Healthcare submitted its response to the GST Authority. After reviewing the company's submissions, the authority passed final orders confirming the demands with applicable interest and penalties. The total confirmed amount of ₹2,139.61 crores represents a significant financial exposure for the healthcare company across the three-year period from FY 2020-21 to FY 2022-23.

Fortis Healthcare has secured a favorable ruling from the Delhi High Court in a civil suit filed against a third party and others. The court's order dated December 19, 2025, decided the case in favor of the company, granting permanent injunction against the third party's actions and upholding the company's challenge to their locus.

Background of the Legal Dispute

The legal proceedings stem from events that occurred in the year ended March 31, 2023. A party claiming to be an assignee of a third party initiated arbitration proceedings against Fortis Healthcare. During these proceedings, an ex-parte interim award was passed, which was subsequently terminated by the arbitrator.

The company disclosed that it neither received any notice nor any statement of claim regarding the arbitration proceedings. In response to these developments, Fortis Healthcare filed a civil suit challenging the locus of the said parties and seeking permanent injunction against their actions.

Court Ruling Details

The following table summarizes the key aspects of the legal settlement:

Financial Impact Assessment

Fortis Healthcare has confirmed that the settlement will have no impact on the company's financial position. The company stated that no compensation or penalty was paid as part of this resolution, and the terms of settlement are not applicable given the nature of the court's ruling in their favor.

Regulatory Compliance

The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company formally notified the stock exchanges on December 23, 2025, at 12:33 p.m., ensuring compliance with regulatory requirements for material event disclosures.

This legal victory provides clarity on the disputed matter and removes any potential uncertainty that may have surrounded the arbitration proceedings initiated against the company.